We are live on ! Find out more
YMRC

Yorktown Management & Research Company Portfolio holdings

AUM $163M
1-Year Est. Return 68.53%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+68.53%
3 Year Est. Return
+222.75%
5 Year Est. Return
+299.09%
10 Year Est. Return
+935.04%
AUM
$128M
AUM Growth
+$7.12M
Cap. Flow
-$288K
Cap. Flow %
-0.23%
Top 10 Hldgs %
15.2%
Holding
278
New
31
Increased
64
Reduced
17
Closed
36

Top Sells

Rank Stock Value
1
GNRC icon
Generac Holdings
GNRC
+$2.05M
2
FN icon
Fabrinet
FN
+$1.66M
3
MLAB icon
Mesa Laboratories
MLAB
+$1.02M
4
ETSY icon
Etsy
ETSY
+$866K
5
ULTA icon
Ulta Beauty
ULTA
+$680K

Sector Composition

Rank Sector Weight
1 Technology 25.74%
2 Healthcare 16.45%
3 Consumer Discretionary 15%
4 Industrials 13.3%
5 Financials 11.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDS icon
76
Factset
FDS
$9.89B
$537K 0.42%
1,600
+700
+78% +$229K
APAM icon
77
Artisan Partners
APAM
$2.97B
$534K 0.42%
10,500
+1,400
+15% +$73.6K
CIEN icon
78
Ciena
CIEN
$61.2B
$529K 0.41%
9,300
+3,400
+58% +$187K
CHE icon
79
Chemed
CHE
$7.07B
$522K 0.41%
1,100
+500
+83% +$240K
XYL icon
80
Xylem
XYL
$28.5B
$522K 0.41%
4,350
ARE icon
81
Alexandria Real Estate Equities
ARE
$8.27B
$519K 0.41%
+2,850
New +$510K
BERY
82
DELISTED
Berry Global Group, Inc.
BERY
$518K 0.41%
8,658
-4,573
-35% -$275K
EBS icon
83
Emergent Biosolutions
EBS
$233M
$517K 0.41%
8,200
+3,800
+86% +$244K
MGIC
84
DELISTED
Magic Software Enterprises
MGIC
$516K 0.4%
31,800
+4,100
+15% +$65.7K
NEOG icon
85
Neogen
NEOG
$2.5B
$516K 0.4%
11,200
+1,400
+14% +$64.7K
OLED icon
86
Universal Display
OLED
$4.23B
$511K 0.4%
2,300
+600
+35% +$131K
TREX icon
87
Trex
TREX
$5.05B
$511K 0.4%
5,000
G icon
88
Genpact
G
$5.7B
$509K 0.4%
11,200
+4,400
+65% +$199K
BIG
89
DELISTED
Big Lots, Inc.
BIG
$508K 0.4%
7,700
+700
+10% +$46.6K
CONE
90
DELISTED
CyrusOne Inc Common Stock
CONE
$508K 0.4%
7,100
+3,000
+73% +$218K
CASH icon
91
Pathward Financial
CASH
$1.78B
$506K 0.4%
+10,000
New +$496K
ICLR icon
92
Icon
ICLR
$12.9B
$506K 0.4%
+2,450
New +$529K
INCY icon
93
Incyte
INCY
$24.5B
$505K 0.4%
+6,000
New +$500K
GLOB icon
94
Globant
GLOB
$1.67B
$504K 0.4%
2,300
+900
+64% +$198K
PHM icon
95
Pultegroup
PHM
$24.6B
$497K 0.39%
9,100
-6,300
-41% -$352K
GMED icon
96
Globus Medical
GMED
$11.5B
$496K 0.39%
6,400
ZNGA
97
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$496K 0.39%
+46,700
New +$492K
CCK icon
98
Crown Holdings
CCK
$13.1B
$491K 0.39%
4,800
-3,200
-40% -$337K
COO icon
99
Cooper Companies
COO
$15B
$491K 0.39%
+4,960
New +$486K
PCTY icon
100
Paylocity
PCTY
$7.73B
$487K 0.38%
2,550

Similar funds

Yorktown Management & Research Company's Q2 2021 Portfolio in Review

As of Q2 2021, Yorktown Management & Research Company held 278 positions worth $128M, up 5.9% from $120M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Yorktown Management & Research Company's Q2 2021 filing shows 31 new, 64 increased, 17 reduced and 36 closed positions. Its largest new stake was ScottsMiracle-Gro: 3,280 shares worth $629K. The largest sale was Generac Holdings, an estimated $2.05M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Yorktown Management & Research Company's largest Q2 2021 buy was ScottsMiracle-Gro: 3,280 shares worth $629K.
  • Yorktown Management & Research Company added most to Enanta Pharmaceuticals in Q2 2021, an estimated $289K increase.
  • Yorktown Management & Research Company's biggest Q2 2021 reduction was Generac Holdings, cutting an estimated $2.05M.
  • Yorktown Management & Research Company fully exited Fabrinet in Q2 2021, selling an estimated $1.66M.
  • Yorktown Management & Research Company's ten largest holdings make up 15% of its $128M portfolio in Q2 2021.
  • Yorktown Management & Research Company opened 31 new positions and closed 36 in Q2 2021.
  • Yorktown Management & Research Company's portfolio value rose 5.9% quarter-over-quarter to $128M.

Based on Yorktown Management & Research Company's 13F filing for Q2 2021, filed 3 Aug 2021.